| SKU | Size | Availability | Price | Qty |
|---|---|---|---|---|
| Ab170526-100μg | 100μg | Available within 8-12 weeks(?) Production requires sourcing of materials. We appreciate your patience and understanding. | $69.90 | |
| Ab170526-1mg | 1mg | In stock | $309.90 | |
| Ab170526-5mg | 5mg | Available within 4-8 weeks(?) Items will be manufactured post-order and can take 4-8 weeks. Thank you for your patience! | $618.90 | |
| Ab170526-10mg | 10mg | Available within 8-12 weeks(?) Production requires sourcing of materials. We appreciate your patience and understanding. | $987.90 |
Purity>95% (SDS-PAGE&SEC); Endotoxin Level<1.0EU/mg; Human IgG1; CHO; ELISA, FACS, Functional assay, Animal Model; Unconjugated
| Product Name | Belantamab (anti-TNFRSF17) - Primary antibody, for ELISA,Functional Assay,Flow cytometry,Kinetics (BLI),Kinetics (SPR) various applications, specific to TNFRSF17, >95%, high purity, Human IgG1 |
|---|---|
| Synonyms | Belantamab | B cell maturation antigen antibody | B cell maturation factor antibody | B cell maturation protein antibody | B-cell maturation protein antibody | BCM antibody | BCMA antibody | CD269 antibody | CD269 antigenantibody | TNFRSF17 antibody | TNR |
| Specifications & Purity | ExactAb™, Validated, Carrier Free, Low Endotoxin, Azide Free, Recombinant, ≥95%(SDS-PAGE&SEC), Lot by Lot |
| Host species | Human |
| Specificity | TNFRSF17 |
| Application | ELISA,Functional Assay,Flow cytometry,Kinetics (BLI),Kinetics (SPR) |
| Conjugation | Unconjugated |
| Grade | Azide Free, Carrier Free, ExactAb™, Low Endotoxin, Recombinant, Validated |
| Product Description | Belantamab is an anti-TNFRSF17 recombinant monoclonal antibody. Belantamab can be used in the synthesis of antibody-drug conjugate (ADC), Belantamab mafodotin. |
| Antibody Type | Primary antibody |
|---|---|
| Clonality | Recombinant |
| Isotype | Human IgG1 |
| Light Chain Type | kappa |
| SDS-PAGE | 27.3 kDa (Light Chain) & 53.5 kDa (Heavy Chain), under reducing conditions; 180.0 kDa, under non-reducing conditions. |
| Purification Method | Protein A purified |
| Purity | >95% |
| Source | CHO supernatant |
| Form | Liquid |
| Concentration | Lot by Lot |
| Storage Temp | Store at -80°C,Avoid repeated freezing and thawing |
| Shipped In | Ice chest + Ice pads |
| Stability And Storage | Store at -80℃ for 24 months. Upon delivery aliquot. Avoid freeze/thaw cycle. |
| CAS | 2061894-48-0 |
Belantamab (anti-TNFRSF17) (Ab170526) - ELISA
Immobilized Recombinant Human TNFRSF17 Protein at 2 μg/mL can bind Belantamab (anti-TNFRSF17) (Ab170526) with the EC50 of 65.95 ng/mL.
Belantamab (anti-TNFRSF17) (Ab170526) - SEC
The purity of Belantamab (anti-TNFRSF17) (Ab170526) is more than 95% verified by HPLC.
Belantamab (anti-TNFRSF17) (Ab170526) - ELISA
Immobilized Recombinant Human BCMA/TNFRSF17 Protein (rp169554) at 0.5 μg/mL can bind Belantamab (anti-TNFRSF17) (Ab170526) with the EC50 of 22.0 ng/mL.
| Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
|---|
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
Enter Lot Number to search for COA:
Find and download the COA for your product by matching the lot number on the packaging.
| Lot Number | Certificate Type | Date | Item |
|---|---|---|---|
 ZJ23F1001461 | Certificate of Analysis | Nov 01, 2023 | Ab170526 |
| ZJ23F1001462 | Certificate of Analysis | Nov 01, 2023 | Ab170526 |
